NAMI vs EVER

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 19, 2026

NAMI

39.8
AI Score
VS
EVER Wins

EVER

42.7
AI Score

Investment Advisor Scores

NAMI

40score
Recommendation
AVOID NEW MONEY

EVER

43score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NAMI EVER Winner
Forward P/E 0 7.2464 Tie
PEG Ratio 0 0 Tie
Revenue Growth -31.9% 24.6% EVER
Earnings Growth 0.0% 35.9% EVER
Tradestie Score 39.8/100 42.7/100 EVER
Profit Margin -23.9% 15.2% EVER
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD EVER

Relative Price Performance (Last 90 Days)

NAMI 1M: -6.6% · 3M: -42.5% EVER 1M: -4.1% · 3M: -17.5%

Current Technical Phase

NAMI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.7%), weak momentum, RSI 42

RSI (14): 42.3 · Price: $1.85

EVER

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.1 · Price: $22.20

Fundamentals Snapshot

Metric NAMI EVER
Market Cap — —
Forward P/E 0.0 7.2
Trailing P/E 0.9 7.1
Revenue (TTM) — —
Revenue Growth -0.3% 0.2%
Gross Margin 0.1% 1.0%
Operating Margin -0.1% 0.1%
EPS 1.93 3.07
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, EVER is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.